Skip to main content
. 2021 Oct 21;8:738947. doi: 10.3389/fcvm.2021.738947

Table 1.

Univariable analysis of preoperative and intraoperative data.

Project Survival group Death group t /χ2/z P
(n = 36) (n = 54)
Sex /male, n (%) 24 (66.7) 32 (62.2) 0.504 0.478
Age, years 56.86 ± 11.30 58.48 ± 10.95 0.679 0.499
Body weight, kg 65.44 ± 13.53 62.36 ± 14.13 1.031 0.305
Height, cm 165.72 ± 9.07 163.86 ± 8.48 0.992 0.324
BMI, kg/m2 23.69 ± 3.86 23.11 ± 4.43 0.647 0.519
Hypertension, n (%) 18 (50.0) 25 (46.3) 0.119 0.730
Diabetes mellitus, n (%) 0 6 (11.1)
History of cardiac surgery, n (%) 5 (13.9) 11 (20.4) 0.621 0.431
LVEF, % 57.53 ± 9.02 55.02 ± 8.30 1.351 0.180
HB, g/L 136.56 ± 31.12 131.63 ± 19.65 0.921 0.360
WBC, × 109/L 8.89 ± 4.31 7.69 ± 4.43 1.283 0.203
PLT, × 109/L 179.28 ± 76.40 176.89 ± 65.04 0.159 0.874
Albumin, g/L 39.65 ± 5.06 40.84 ± 5.23 1.068 0.288
TB, μmmol/L 19.45 ± 13.15 21.90 ± 12.81 0.878 0.382
ALT, U/L 33.33 ± 29.79 29.26 ± 19.22 0.789 0.432
AST, U/L 35.58 ± 24.69 31.43 ± 18.16 0.920 0.360
Urea nitrogen, μmmol/L 6.84 ± 2.07 7.78 ± 6.21 0.870 0.387
Creatinine, mmol/L 76.30 ± 19.75 78.31 ± 25.50 0.400 0.690
eGFR, ml/min 97.28 ± 15.94 91.26 ± 18.29 1.602 0.113
Operative time, h 7.49 ± 2.19 7.02 ± 2.49 0.916 0.362
Cardiopulmonary bypass time, min 190.8 (143.0) 160.8 (76.0) 1.582 0.114
Cross clamp time, min 127.8 (102.0) 124.2 (51.0) 0.644 0.520
Transfusion of red blood cells, U 6.35 ± 4.883 5.07 ± 4.24 1.330 0.187
Plasma transfused, ml 759.72 ± 617.93 695.37 ± 635.08 0.476 0.635
Intraoperative urine output, ml 855.71 ± 623.93 936.23 ± 726.88 0.537 0.592

Values are mean ± SD, median (interquartile range), or percentages.

BMI, body mass index; LVEF, left ventricular ejection fraction; HB, hemoglobin; WBC, white blood cell; PLT, platelet; TB, total bilirubin; ALT, alanine transaminase; AST, glutamic oxalacetic transaminase; eGFR, glomerular filtration rate.